-
-
-
-
-
-
-
QIAGEN Exceeds Q4 2025 Outlook Driven by Growth Pillars
-
-
-
-
-
-
-
QIAGEN Exceeds Q3 2025 Outlook, Raises FY 2025 Adj. EPS Target, Announces Parse Acquisition and $500 Million Share Repurchase
-
-
-
-
-
-
-
QIAGEN enhances leading clinical genomics portfolio with acquisition of Genoox AI-powered software
-
-
-
-
-
-
-
Qiagen (QGEN) announces preliminary Q2 2021 results exceeding outlook; plans new $100 million share repurchase program
-
-
-
-
-
-
-
QIAGEN (QGEN) to Continue Growth Strategy Focused on Execution and Greater Value Creation
-
-
-
-
-
-
-
Thermo Fisher Scientific and QIAGEN N.V. Agree on Amended Terms to Acquisition Agreement
-
-
-
-
-
-
-
Thermo Fisher Scientific Publishes Offer Document for Voluntary Tender Offer for All Ordinary Shares of QIAGEN N.V.
-
1,181,593 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

